- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有132家主力机构披露2025-12-31报告期持股数据，持仓量总计4.67亿股，占流通A股49.11%
- 波段诊断：
-
技术面诊股
诊断结果：5.9技术面打败了42%的股票
技术面评分前10的股票
近期的平均成本为14.69元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为14.69元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.69","date":1776587507,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2026.04.20","stock":"-1.01","trade":"-0.37","ind":"0.76"},{"date":"2026.04.17","stock":"-2.80","trade":"-1.46","ind":"-0.10"},{"date":"2026.04.16","stock":"0.33","trade":"-0.14","ind":"0.70"},{"date":"2026.04.15","stock":"-2.49","trade":"2.24","ind":"0.01"},{"date":"2026.04.14","stock":"-0.25","trade":"0.68","ind":"0.95"},{"date":"2026.04.13","stock":"-1.63","trade":"-0.85","ind":"0.06"},{"date":"2026.04.10","stock":"-1.18","trade":"0.52","ind":"0.51"},{"date":"2026.04.09","stock":"-0.19","trade":"-2.18","ind":"-0.72"},{"date":"2026.04.08","stock":"-1.10","trade":"1.06","ind":"2.70"},{"date":"2026.04.07","stock":"3.87","trade":"0.46","ind":"0.26"},{"date":"2026.04.03","stock":"-1.13","trade":"-2.72","ind":"-1.00"},{"date":"2026.04.02","stock":"-1.79","trade":"1.12","ind":"-0.74"},{"date":"2026.04.01","stock":"1.00","trade":"4.62","ind":"1.46"},{"date":"2026.03.31","stock":"-3.19","trade":"-0.68","ind":"-0.80"},{"date":"2026.03.30","stock":"4.40","trade":"0.96","ind":"0.24"},{"date":"2026.03.27","stock":"3.31","trade":"4.54","ind":"0.63"},{"date":"2026.03.26","stock":"1.85","trade":"-0.58","ind":"-1.09"},{"date":"2026.03.25","stock":"0.87","trade":"1.24","ind":"1.30"},{"date":"2026.03.24","stock":"1.56","trade":"4.01","ind":"1.78"},{"date":"2026.03.23","stock":"-2.96","trade":"-5.71","ind":"-3.63"},{"date":"2026.03.20","stock":"-2.94","trade":"-2.21","ind":"-1.24"}]
浙江医药,上证指数,化学制药指数
压力支撑
该股压力位为14.71元，支撑位为14.54元。
[{"text":"\u538b\u529b\u4f4d","value":"14.71","date":1776614400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.54","date":1776614400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.4资金面打败了1%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：04月20日 20:31
| 机构今日流向(万元) | -2263.97 | 机构5日流向(万元) | -6878.15 |
| 机构10日流向(万元) | -15113.11 | 机构20日流向(万元) | -13310.59 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1938.6万股，其中基金净减仓19家，主力净减仓67家，请投资者中长期谨慎为宜。
截止2025-12-31，共132家主力机构（基金128家，一般法人4家），持仓量总计46725.84万股，占流通A股49.11%
其中，基金持仓与2025-06-30相比：
增仓：23家 ，增持 629.06万股
减仓：42家 ，减持 117.94万股
新出现在主力名单中：60家 ，持有629.55万股
从主力名单中消失：127家 ，原持有1141.37万股
其中，基金持仓与2025-06-30相比：
增仓：23家 ，增持 629.06万股
减仓：42家 ，减持 117.94万股
新出现在主力名单中：60家 ，持有629.55万股
从主力名单中消失：127家 ，原持有1141.37万股
消息面诊股
诊断结果：6.1消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 基础化工行业周报：能源价格震荡加剧化工品价差波动，
2026-04-20 - 浙江医药：4月17日获融资买入5765.43万元
2026-04-18 - 浙江医药：4月16日获融资买入6049.30万元
2026-04-17 - 政策发力地缘博弈 重塑化工新格局
2026-04-16 - 浙江医药：4月15日获融资买入8163.86万元
2026-04-16 - 【浙江医药】维生素价格大涨26年业绩可期，子公司新
2026-04-16 - 浙江医药：4月14日获融资买入5136.25万元
2026-04-15 - A股药企薪酬图鉴：谁家天花板？谁家脚底板？
2026-04-14 - ADC：又一家，拟分拆去港股IPO
2026-04-14 - 浙江医药：4月13日获融资买入1.36亿元
2026-04-14
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-04-11 |
| 利好 | 分红转增 | 10派2.80元(含税) | 2026-04-11 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-08 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-31 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-04 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-06-25 |
| 利好 | 分红转增 | 10派3.7元(含税) | 2025-04-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.1行业面打败了70%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.04.20","price":"0.76","value":"-0.37"},{"date":"2026.04.17","price":"-0.10","value":"-1.46"},{"date":"2026.04.16","price":"0.70","value":"-0.14"},{"date":"2026.04.15","price":"0.01","value":"2.24"},{"date":"2026.04.14","price":"0.95","value":"0.68"},{"date":"2026.04.13","price":"0.06","value":"-0.85"},{"date":"2026.04.10","price":"0.51","value":"0.52"},{"date":"2026.04.09","price":"-0.72","value":"-2.18"},{"date":"2026.04.08","price":"2.70","value":"1.06"},{"date":"2026.04.07","price":"0.26","value":"0.46"},{"date":"2026.04.03","price":"-1.00","value":"-2.72"},{"date":"2026.04.02","price":"-0.74","value":"1.12"},{"date":"2026.04.01","price":"1.46","value":"4.62"},{"date":"2026.03.31","price":"-0.80","value":"-0.68"},{"date":"2026.03.30","price":"0.24","value":"0.96"},{"date":"2026.03.27","price":"0.63","value":"4.54"},{"date":"2026.03.26","price":"-1.09","value":"-0.58"},{"date":"2026.03.25","price":"1.30","value":"1.24"},{"date":"2026.03.24","price":"1.78","value":"4.01"},{"date":"2026.03.23","price":"-3.63","value":"-5.71"},{"date":"2026.03.20","price":"-1.24","value":"-2.21"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 美诺华 | 84.66% | 6.95% | 6.1分 |
| 2 | 津药药业 | 60.25% | 8.46% | 4.8分 |
| 3 | 莱美药业 | 38.09% | 8.35% | 4.6分 |
| 4 | 昂利康 | 37.19% | 33.24% | 5.5分 |
| 5 | 纳微科技 | 31.95% | -3.44% | 5.4分 |
| 6 | 双鹭药业 | 30.53% | 5.84% | 3.7分 |
| 8 | 华纳药厂 | 26.68% | -5.85% | 4.1分 |
| 10 | 益方生物 | 24.66% | 4.55% | 4.4分 |
| 12 | 赛分科技 | 23.11% | 6.98% | 6.1分 |
| 14 | 通化金马 | 20.54% | 5.04% | 5.2分 |
| 16 | 翰宇药业 | 20.10% | 3.38% | 6.0分 |
| 18 | 亚太药业 | 19.81% | 3.07% | 4.5分 |
| 20 | 博瑞医药 | 19.21% | 15.77% | 4.7分 |
| 22 | 海森药业 | 16.35% | -2.76% | 4.9分 |
| 24 | 泽璟制药 | 15.65% | 0.22% | 4.9分 |
| 26 | 北大医药 | 15.38% | 7.49% | 4.9分 |
| 28 | - | 14.82% | 3.44% | 分 |
| 30 | 首药控股 | 14.55% | 4.88% | 5.0分 |
| 32 | 金城医药 | 13.13% | 3.64% | 5.9分 |
| 34 | 海思科 | 12.93% | -4.95% | 6.0分 |
| 36 | 奥赛康 | 11.49% | -0.38% | 4.2分 |
| 38 | 金陵药业 | 10.99% | 8.69% | 5.7分 |
| 40 | 悦康药业 | 9.05% | 3.72% | 4.6分 |
| 42 | 共同药业 | 8.95% | 2.78% | 5.1分 |
| 44 | 海欣股份 | 8.69% | 2.74% | 5.9分 |
| 46 | 海正药业 | 8.34% | 9.19% | 5.6分 |
| 48 | 奥翔药业 | 8.25% | -2.16% | 4.5分 |
| 50 | 东诚药业 | 8.11% | 1.08% | 4.9分 |
| 52 | 百济神州 | 7.75% | 1.34% | 5.0分 |
| 54 | 力生制药 | 7.66% | 1.21% | 5.2分 |
| 56 | 艾力斯 | 6.83% | 0.44% | 4.4分 |
| 58 | - | 6.08% | 4.71% | 分 |
| 60 | - | 5.78% | 7.01% | 分 |
| 62 | 海南海药 | 5.73% | 3.36% | 5.4分 |
| 64 | 尔康制药 | 5.63% | -2.96% | 4.4分 |
| 66 | - | 5.39% | 1.70% | 分 |
| 68 | - | 4.84% | 5.16% | 分 |
| 70 | 奥锐特 | 4.55% | 0.33% | 4.9分 |
| 72 | 西点药业 | 4.49% | -2.13% | 5.1分 |
| 74 | 上海谊众 | 4.35% | -3.23% | 4.5分 |
| 76 | 多瑞医药 | 4.33% | 24.30% | 5.2分 |
| 78 | 丰原药业 | 4.14% | -0.30% | 5.7分 |
| 80 | 复星医药 | 4.06% | -1.82% | 4.6分 |
| 82 | - | 3.57% | 1.68% | 分 |
| 84 | 本立科技 | 3.30% | 2.77% | 5.8分 |
| 86 | 灵康药业 | 3.00% | -0.89% | 4.8分 |
| 88 | 东北制药 | 2.75% | -0.95% | 4.8分 |
| 90 | 福安药业 | 2.45% | 0.48% | 4.7分 |
| 92 | 东亚药业 | 2.16% | 4.25% | 5.0分 |
| 94 | 立方制药 | 2.00% | -0.08% | 4.8分 |
| 96 | 盟科药业 | 1.82% | -0.32% | 4.2分 |
| 98 | 华仁药业 | 1.63% | -1.27% | 5.6分 |
| 100 | 华邦健康 | 1.17% | 0.78% | 5.2分 |
| 102 | 海普瑞 | 1.00% | 0.18% | 5.2分 |
| 104 | 福元医药 | 0.77% | -3.09% | 4.7分 |
| 106 | ST诺泰 | 0.69% | -1.68% | 4.9分 |
| 108 | 必贝特 | 0.68% | 1.76% | 5.0分 |
| 110 | 京新药业 | 0.40% | -4.23% | 4.9分 |
| 112 | 山河药辅 | 0.21% | 0.14% | 5.7分 |
| 114 | 新和成 | 0.15% | -10.37% | 5.1分 |
| 116 | 赛托生物 | 0.07% | -1.89% | 5.6分 |
| 118 | 健康元 | 0.00% | 0.37% | 5.0分 |
| 120 | 仙琚制药 | -0.11% | 0.45% | 4.7分 |
| 122 | 宣泰医药 | -0.64% | -0.64% | 4.2分 |
| 124 | 德展健康 | -0.89% | -2.62% | 3.4分 |
| 126 | 卫信康 | -1.06% | -1.53% | 5.0分 |
| 128 | 科伦药业 | -1.19% | -2.05% | 4.8分 |
| 130 | 华东医药 | -1.54% | -1.43% | 5.0分 |
| 132 | 向日葵 | -1.74% | 0.25% | 4.8分 |
| 134 | 九典制药 | -2.12% | -1.14% | 4.1分 |
| 136 | 哈三联 | -2.54% | -4.63% | 3.8分 |
| 138 | 浙江医药 | -2.96% | -6.11% | 5.0分 |
| 140 | 天新药业 | -3.30% | -0.41% | 4.7分 |
| 142 | 健友股份 | -3.67% | -2.57% | 4.6分 |
| 144 | 广济药业 | -4.41% | -3.59% | 5.4分 |
| 146 | 恩华药业 | -5.11% | -4.85% | 4.7分 |
| 148 | 莎普爱思 | -5.81% | -4.42% | 4.5分 |
| 150 | 国药现代 | -6.62% | -1.02% | 4.5分 |
| 152 | 国邦医药 | -7.70% | -3.62% | 4.9分 |
| 154 | 溢多利 | -9.59% | -2.20% | 4.9分 |
| 156 | 能特科技 | -12.46% | -5.70% | 4.5分 |
| 158 | 科源制药 | -22.59% | -0.47% | 5.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-12-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/219 ， 40/219。
[{"date":"2025-12-31","value":"8.09","vol":"-2.79"},{"date":"2025-09-30","value":"8.60","vol":"1.50"},{"date":"2025-06-30","value":"6.16","vol":"1.22"},{"date":"2025-03-31","value":"3.77","vol":"-0.14"},{"date":"2024-12-31","value":"11.45","vol":"19.49"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
8.09 | 8.60 | 6.16 | 3.77 | 11.45 |
| 行业(%) | -2.79 | 1.50 | 1.22 | -0.14 | 19.49 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"34.67","vol":"52.27"},{"date":"2025-09-30","value":"37.49","vol":"49.37"},{"date":"2025-06-30","value":"39.82","vol":"49.34"},{"date":"2025-03-31","value":"43.40","vol":"49.16"},{"date":"2024-12-31","value":"42.33","vol":"50.51"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
34.67 | 37.49 | 39.82 | 43.40 | 42.33 |
| 行业(%) | 52.27 | 49.37 | 49.34 | 49.16 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 36/219 ， 34/219。
[{"date":"2025-12-31","value":"-5.28","vol":"5.19"},{"date":"2025-09-30","value":"-5.87","vol":"142.64"},{"date":"2025-06-30","value":"-1.87","vol":"79.13"},{"date":"2025-03-31","value":"0.28","vol":"-0.03"},{"date":"2024-12-31","value":"20.29","vol":"17.80"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.28 | -5.87 | -1.87 | 0.28 | 20.29 |
| 行业(%) | 5.19 | 142.64 | 79.13 | -0.03 | 17.80 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"-24.74","vol":"-30.23"},{"date":"2025-09-30","value":"9.83","vol":"-2.91"},{"date":"2025-06-30","value":"113.52","vol":"58.54"},{"date":"2025-03-31","value":"273.08","vol":"-10.77"},{"date":"2024-12-31","value":"170.11","vol":"-75.44"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-24.74 | 9.83 | 113.52 | 273.08 | 170.11 |
| 行业(%) | -30.23 | -2.91 | 58.54 | -10.77 | -75.44 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 9/219 ， 20/219。
[{"date":"2025-12-31","value":"0.64","vol":"0.42"},{"date":"2025-09-30","value":"0.48","vol":"0.31"},{"date":"2025-06-30","value":"0.31","vol":"0.21"},{"date":"2025-03-31","value":"0.16","vol":"0.10"},{"date":"2024-12-31","value":"0.71","vol":"0.43"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.64 | 0.48 | 0.31 | 0.16 | 0.71 |
| 行业(次) | 0.42 | 0.31 | 0.21 | 0.10 | 0.43 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"2.91","vol":"2.74"},{"date":"2025-09-30","value":"2.03","vol":"1.94"},{"date":"2025-06-30","value":"1.20","vol":"1.30"},{"date":"2025-03-31","value":"0.61","vol":"0.66"},{"date":"2024-12-31","value":"2.61","vol":"3.18"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.91 | 2.03 | 1.20 | 0.61 | 2.61 |
| 行业(次) | 2.74 | 1.94 | 1.30 | 0.66 | 3.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/219 ， 19/219。
[{"date":"2025-12-31","value":"18.17","vol":"16.98"},{"date":"2025-09-30","value":"29.10","vol":"4.25"},{"date":"2025-06-30","value":"23.86","vol":"2.97"},{"date":"2025-03-31","value":"13.52","vol":"-26.71"},{"date":"2024-12-31","value":"23.48","vol":"-371.76"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.17 | 29.10 | 23.86 | 13.52 | 23.48 |
| 行业 | 16.98 | 4.25 | 2.97 | -26.71 | -371.76 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.56","vol":"1.16"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.54","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.95","vol":"1.99"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.56 | - | 0.54 | - | 0.95 |
| 行业 | 1.16 | 0.00 | 1.71 | 0.00 | 1.99 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 27/219 ， 31/219。
[{"date":"2025-12-31","value":"2.96","vol":"3.34"},{"date":"2025-09-30","value":"2.79","vol":"3.48"},{"date":"2025-06-30","value":"2.98","vol":"3.67"},{"date":"2025-03-31","value":"2.85","vol":"3.59"},{"date":"2024-12-31","value":"2.56","vol":"3.34"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.96 | 2.79 | 2.98 | 2.85 | 2.56 |
| 行业 | 3.34 | 3.48 | 3.67 | 3.59 | 3.34 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"2.13","vol":"2.77"},{"date":"2025-09-30","value":"1.95","vol":"2.73"},{"date":"2025-06-30","value":"2.00","vol":"2.88"},{"date":"2025-03-31","value":"1.91","vol":"2.81"},{"date":"2024-12-31","value":"1.67","vol":"2.63"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.13 | 1.95 | 2.00 | 1.91 | 1.67 |
| 行业 | 2.77 | 2.73 | 2.88 | 2.81 | 2.63 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/219 ， 38/219。
[{"date":"2025-12-31","value":"21.30","vol":"34.85"},{"date":"2025-09-30","value":"20.69","vol":"34.03"},{"date":"2025-06-30","value":"19.80","vol":"34.15"},{"date":"2025-03-31","value":"19.51","vol":"34.38"},{"date":"2024-12-31","value":"21.22","vol":"34.54"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
21.30 | 20.69 | 19.80 | 19.51 | 21.22 |
| 行业(%) | 34.85 | 34.03 | 34.15 | 34.38 | 34.54 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.27","vol":"2.93"},{"date":"2025-09-30","value":"0.26","vol":"1.19"},{"date":"2025-06-30","value":"0.25","vol":"0.88"},{"date":"2025-03-31","value":"0.25","vol":"1.46"},{"date":"2024-12-31","value":"0.27","vol":"0.83"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.27 | 0.26 | 0.25 | 0.25 | 0.27 |
| 行业(%) | 2.93 | 1.19 | 0.88 | 1.46 | 0.83 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"5.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.30","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.61","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.73","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"12.98","blueLineValue":"1.35","type":"YC"}]